Tumor necrosis factor inhibitors are associated with reduced complement activation in spondylarthropathies: An observational study

BACKGROUND: The complement system is involved in pathogenesis of cardiovascular disease, and might play a role in accelerated atherogenesis in spondylarthropathies (SpA). Hence, we examined complement activation in SpA, and its relationship to antirheumatic treatment, inflammatory and cardiovascular...

Descripción completa

Detalles Bibliográficos
Autores principales: Hokstad, Ingrid, Deyab, Gia, Wang Fagerland, Morten, Lyberg, Torstein, Hjeltnes, Gunnbjørg, Førre, Øystein, Agewall, Stefan, Mollnes, Tom Eirik, Hollan, Ivana
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6650069/
https://www.ncbi.nlm.nih.gov/pubmed/31335881
http://dx.doi.org/10.1371/journal.pone.0220079

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6650069/
https://www.ncbi.nlm.nih.gov/pubmed/31335881
http://dx.doi.org/10.1371/journal.pone.0220079

Ejemplares similares